Brittany Chubbs

2 papers in the library · 11 citations · publishing 2022-2024

Papers

Sort Most recent Most cited

Patient-reported outcomes on sleep quality and circadian rhythm during treatment with intravenous ketamine for treatment-resistant depression.

Therapeutic Advances in Psychopharmacology 2024 Raymond Yan, Tyler Marshall, Atul Khullar et al. 11 citations

Intravenous (IV) ketamine is a rapid acting antidepressant used primarily for treatment-resistant depression (TRD). It has been suggested that IV ketamine's rapid antidepressant effects may be partially mediated via improved sleep and changes to the circadian rhythm. This study explores IV ketamine's association with changes in patient-reported sleep quality and circadian rhythm in an adult...

DOI: 10.1177/20451253241231264 Full text Ketamine Treatment-resistant depression Circadian rhythm Patient-reported outcomes +8

A survey of drug liking and cravings in patients using sublingual or intranasal ketamine for treatment resistant depression: A preliminary evaluation of real world addictive potential

Frontiers in Psychiatry November 17, 2022 Brittany Chubbs, Jay Wang, S. Archer et al.

Ketamine has gained rapid popularity as a treatment option for treatment resistant depression (TRD). Though seen only in limited contexts, ketamine is a potential drug of abuse, addiction and diversion. Clinical ketamine studies to date have not systematically evaluated factors relevant to addiction risk in patients with TRD, but in treating patients with ketamine, risks of potential harms...

DOI: 10.3389/fpsyt.2022.1016439 Full text